Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.22 EUR | +4.72% | -0.45% | -27.45% |
Apr. 30 | Groupe Berkem Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 06 | Givaudan: agreement signed with Berkem | CF |
Chart calendar Groupe Berkem
Upcoming events on Groupe Berkem
Past events on Groupe Berkem
2024-04-28 | Q1 2024 Sales and Revenue Release |
2024-04-28 | Q4 2023 Earnings Release |
2024-01-30 | Q4 2023 Sales and Revenue Release |
2023-10-24 12:00 pm | Q2 2023 Earnings Release |
2023-07-30 | Q2 2023 Sales and Revenue Release - Revenue Release |
2023-06-22 10:00 am | Annual General Meeting |
2023-05-16 01:30 pm | Q4 2022 Earnings Release |
2023-04-27 12:00 pm | Q1 2023 Sales and Revenue Release |
2023-01-31 12:00 pm | FY 2022 Sales and Revenue Release |
2022-10-19 | Q3 2022 Sales and Revenue Release |
2022-09-29 12:00 pm | Interim 2022 Earnings Release |
2022-07-21 12:00 pm | Interim 2022 Sales and Revenue Release |
2022-06-03 10:30 am | Annual General Meeting |
2022-04-19 12:17 pm | FY 2021 Earnings Release |
2022-01-26 12:00 pm | FY 2021 Sales and Revenue Release |
Past dividends on Groupe Berkem
2022-07-03 | Annual 0.06 EUR |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 40,6 | 46,1 46,0 0.14% | 51,8 49,8 4.12% | 52,4 53,2 -1.5% |
EBITDA Million EUR | Released Forecast Spread | 0,00 | 9,20 9,00 2.22% | 7,89 8,13 -2.94% | 5,95 5,17 15.16% |
EBIT Million EUR | Released Forecast Spread | 0,00 | 5,56 5,95 -6.55% | 3,61 4,33 -16.72% | 2,56 2,73 -6.45% |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 | 1,50 -1,00 249.7% | -1,40 3,35 -141.73% | 0,62 2,40 -74.38% |
Net income Million EUR | Released Forecast Spread | 1,44 | 0,53 0,70 -23.71% | -1,57 2,57 -161.06% | 0,37 2,23 -83.56% |
EPS EUR | Released Forecast Spread | 0,00 | 0,01 0,03 -66.67% | -0,09 0,15 -158.7% | 0,02 0,13 -84.95% |
Announcement Date | 10/11/21 | 19/04/22 | 16/05/23 | 07/05/24 |
Quarterly results
Fiscal Period | December | 2022 Q4 | 2023 S1 |
---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 12,5 10,3 21.36% | |
EBITDA Million EUR | Released Forecast Spread | 2,79 3,30 -15.33% | |
Announcement Date | 16/05/23 | - |
Past sector events for Groupe Berkem
Today | SHILPA MEDICARE LIMITED: Q4 2024 Earnings Release |
Today | ORCHID PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-21 | GLAND PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-21 06:57 am | ERIS LIFESCIENCES LIMITED: Q4 2024 Earnings Release |
2024-05-20 05:00 pm | TARO PHARMACEUTICAL INDUSTRIES LTD.: Q4 2024 Earnings Release |
2024-05-17 08:52 am | J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
2024-05-17 04:28 am | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
2024-05-15 10:05 am | MANKIND PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-15 01:30 am | DERMAPHARM HOLDING SE: Q1 2024 Earnings Release |
2024-05-15 07:40 am | CRESCO LABS INC.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALKEM Stock
- Calendar Groupe Berkem